Pain Therapeutics To Present At The CIBC Healthcare Conference
SOUTH SAN FRANCISCO, Nov. 2 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc. , a biopharmaceutical company, today announced that Remi Barbier, president and chief executive officer, will present at the CIBC World Markets Annual Healthcare Conference in New York on Wednesday, November 9th at 1:30 p.m. Eastern Time.
An audio webcast of the live presentation will be open to all on the Pain Therapeutics web site, www.paintrials.com. A replay will also be available after the live event through November 23, 2005.
About Pain Therapeutics, Inc.
Pain Therapeutics is an emerging biopharmaceutical company that develops novel drugs. Our investigational drug candidates target different types of chronic pain, such as low-back pain, pain due to osteoarthritis or irritable bowel syndrome. Pain Therapeutics has three unique drugs in Phase III clinical development: Remoxy(TM), Oxytrex(TM) and PTI-901.Pain Therapeutics, Inc.
CONTACT: Christi Waarich, Senior Manager of Investor Relations of PainTherapeutics, Inc., +1-650-825-3324, or firstname.lastname@example.org; or media,Carney Duntsch of Burns McClellan, +1-212-213-0006, for Pain Therapeutics,Inc.
Web site: http://www.paintrials.com/